Nichi-Iko Pharmaceutical Co.,Ltd. 4541Short Interest

No institution currently reports a short position of 0.5% or more in Nichi-Iko Pharmaceutical Co.,Ltd. (4541). The last disclosure was on 2023-03-08 (Integrated Core Strategies (Asia) Pte. Ltd., 0.47%).

TSE 1st Section (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
582 reports

Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 2 institutions whose last report is more than a year old (1.26% in total). It also excludes 10 institutions that fell below 0.5%. How estimates are calculated

Disclosure History Summary

First disclosure2017-08-29
Latest disclosure2023-03-08 (Integrated Core Strategies (Asia) Pte. Ltd., 0.47%)
Reporting institutions15 firms (582 reports)
Peak estimated short interest7.88% (2022-06-02, 6 holders)

Short Interest Trend Last 5 years, by institution, % of shares outstanding

Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.

  • UBS AG
  • GOLDMAN SACHS INTERNATIONAL
  • Nomura International plc
  • Integrated Core Strategies (Asia) Pte. Ltd.
  • JPM Securities Japan Co Ltd.
  • Others
0.00%
Estimated short interest, 2026-11-18

Current Positions by Short Seller Latest report of each holder

Last report Short seller Position (shares) Ratio Change Status
2018-07-23 Wellington Management Company LLP on behalf of Hawkes Bay Master Investors (Cayman) LP   Position 442,800 shares Ratio 0.72% ▲0.11% +71,300 No report for 1+ year
2019-10-02 Wellington Management Company LLP on behalf of Hawkes Bay Master Investors (Cayman) LP Position 354,605 shares Ratio 0.54% ▼0.16% No report for 1+ year
2017-12-28 Credit Suisse Securities (Europe) Limited Position 302,180 shares Ratio 0.49% ▼0.08% −45,893 Below 0.5%
2020-01-07 Wellington Management Company LLP on behalf of Hawkes Bay Master Investors (Cayman) LP Position 319,405 shares Ratio 0.49% ▼0.05% −126,865 Below 0.5%
2021-12-21 MERRILL LYNCH INTERNATIONAL Position 352,513 shares Ratio 0.49% ▼0.03% −23,500 Below 0.5%
2022-06-14 JPM Securities Japan Co Ltd. Position 343,174 shares Ratio 0.48% ▼0.04% −29,390 Below 0.5%
2022-12-21 GOLDMAN SACHS INTERNATIONAL Position 346,274 shares Ratio 0.48% ▼0.14% −99,000 Below 0.5%
2018-04-05 Deutsche Bank Aktiengesellschaft, London Position 287,408 shares Ratio 0.47% ▼0.12% −75,500 Below 0.5%
2023-03-08 Integrated Core Strategies (Asia) Pte. Ltd. Position 341,102 shares Ratio 0.47% ▼0.12% −86,100 Below 0.5%
2022-11-11 Nomura International plc Position 320,800 shares Ratio 0.44% ▼0.10% −67,600 Below 0.5%
2022-09-21 Morgan Stanley MUFG Securities Co., Ltd. Position 303,656 shares Ratio 0.42% ▼0.26% −188,000 Below 0.5%
2023-02-06 UBS AG Position 240,130 shares Ratio 0.33% ▼0.25% −180,200 Below 0.5%
2021-04-02 J.P. MORGAN SECURITIES PLC Position 0 shares Ratio 0.00% ▼0.50% −331,964 Closed
2022-07-14 Credit Suisse AG Position 0 shares Ratio 0.00% ▼0.56% −401,192 Closed
2022-09-05 BNP Paribas Arbitrage SNC Position 0 shares Ratio 0.00% ▼0.57% −407,850 Closed

Disclosure History 582 in total

Trade date Short seller Position (shares) Ratio Change Note
2023-03-08 Integrated Core Strategies (Asia) Pte. Ltd. Position 341,102 shares Ratio 0.47% ▼0.12% −86,100 Below 0.5%
2023-02-27 Integrated Core Strategies (Asia) Pte. Ltd. Position 427,202 shares Ratio 0.59% ▼0.10% −69,600 —
2023-02-06 UBS AG Position 240,130 shares Ratio 0.33% ▼0.25% −180,200 Below 0.5%
2023-01-31 UBS AG Position 420,330 shares Ratio 0.58% ▼0.09% −61,700 —
2023-01-30 Integrated Core Strategies (Asia) Pte. Ltd. Position 496,802 shares Ratio 0.69% ▼0.09% −60,800 —
2023-01-26 UBS AG Position 482,030 shares Ratio 0.67% ▼0.10% −73,500 —
2023-01-24 Integrated Core Strategies (Asia) Pte. Ltd. Position 557,602 shares Ratio 0.78% ▼0.09% −70,500 —
2023-01-20 UBS AG Position 555,530 shares Ratio 0.77% ▼0.10% −69,400 —
2023-01-18 UBS AG Position 624,930 shares Ratio 0.87% ▲0.31% +218,500 —
2023-01-17 UBS AG Position 406,430 shares Ratio 0.56% ▼0.04% −25,900 —
2023-01-16 UBS AG Position 432,330 shares Ratio 0.60% ▲0.02% +15,400 —
2023-01-16 Integrated Core Strategies (Asia) Pte. Ltd. Position 628,102 shares Ratio 0.87% ▼0.19% −130,300 —
2023-01-13 UBS AG Position 416,930 shares Ratio 0.58% ▲0.11% +386,400 —
2023-01-12 Integrated Core Strategies (Asia) Pte. Ltd. Position 758,402 shares Ratio 1.06% ▲0.64% +464,200 —
2022-12-21 GOLDMAN SACHS INTERNATIONAL Position 346,274 shares Ratio 0.48% ▼0.14% −99,000 Below 0.5%
2022-12-20 GOLDMAN SACHS INTERNATIONAL Position 445,274 shares Ratio 0.62% ▼0.24% −174,300 —
2022-12-16 GOLDMAN SACHS INTERNATIONAL Position 619,574 shares Ratio 0.86% ▲0.37% +263,000 —
2022-12-15 GOLDMAN SACHS INTERNATIONAL Position 356,574 shares Ratio 0.49% ▼0.04% −23,500 Below 0.5%
2022-12-13 UBS AG Position 30,530 shares Ratio 0.04% ▼1.01% −719,500 Below 0.5%
2022-12-13 GOLDMAN SACHS INTERNATIONAL Position 380,074 shares Ratio 0.53% ▼0.10% −75,100 —
2022-12-12 UBS AG Position 750,030 shares Ratio 1.05% ▼0.64% −457,800 —
2022-12-09 UBS AG Position 1,207,830 shares Ratio 1.69% ▼0.02% −17,900 —
2022-12-09 GOLDMAN SACHS INTERNATIONAL Position 455,174 shares Ratio 0.63% ▼0.12% −87,200 —
2022-12-08 UBS AG Position 1,225,730 shares Ratio 1.71% ▼0.32% −227,800 —
2022-12-02 GOLDMAN SACHS INTERNATIONAL Position 542,374 shares Ratio 0.75% ▼0.13% −86,400 —
2022-12-01 Integrated Core Strategies (Asia) Pte. Ltd. Position 294,202 shares Ratio 0.41% ▼0.30% −214,300 Below 0.5%
2022-11-30 UBS AG Position 1,453,530 shares Ratio 2.03% ▲0.12% +88,500 —
2022-11-30 Integrated Core Strategies (Asia) Pte. Ltd. Position 508,502 shares Ratio 0.71% ▲0.09% +65,610 —
2022-11-30 GOLDMAN SACHS INTERNATIONAL Position 628,774 shares Ratio 0.88% ▼0.10% −77,592 —
2022-11-29 UBS AG Position 1,365,030 shares Ratio 1.91% ▲0.27% +192,150 —

Shorted Stocks in the Same Industry Pharmaceutical

Stock Estimated ratio Short sellers
GNI Group Ltd.2160 11.16% 7 firms
Oncolys BioPharma Inc.4588 10.35% 7 firms
HEALIOS K.K.4593 10.20% 5 firms
SymBio Pharmaceuticals Limited4582 9.46% 7 firms
Nxera Pharma Co.,Ltd.4565 7.35% 5 firms

Related Stocks Same TSE 33 sector

Stock Market TSE 33 Sector TOPIX-17 Sector Index
ONO PHARMACEUTICAL CO.,LTD.4528 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
SANTEN PHARMACEUTICAL CO.,LTD.4536 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
Fuso Pharmaceutical Industries,Ltd.4538 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 2
NIPPON CHEMIPHAR CO.,LTD.4539 Standard Market(Domestic) Pharmaceutical Pharmaceutical
TSUMURA & CO.4540 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Mid400
KISSEI PHARMACEUTICAL CO.,LTD.4547 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
SEIKAGAKU CORPORATION4548 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 2
EIKEN CHEMICAL CO.,LTD.4549 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
JCR Pharmaceuticals Co.,Ltd.4552 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1
TOWA PHARMACEUTICAL CO.,LTD.4553 Prime Market (Domestic) Pharmaceutical Pharmaceutical TOPIX Small 1